We're gearing up to participate in the #WSPHAssociation 7th World Symposium on Pulmonary Hypertension, taking place in Barcelona, Spain from June 29 to July 1. For ongoing updates from #WSPH2024, follow our Global Medical Affairs updates on X (formerly Twitter) here: https://bit.ly/4ciuzK8
United Therapeutics Corporation’s Post
More Relevant Posts
-
A new meta-analysis aimed to assess whether #semaglutide exerts greater effects on #glycaemia and other cardiometabolic risk factors compared with other GLP-1RAs. Was semaglutide more effective than other GLP-1RAs for controlling HbA1C? Body weight? Blood pressure? And how did the AE profile compare? A free summary slide deck of the analysis is now available on the CardioMetabolicForum: https://lnkd.in/ewxU-Uyy
-
Exciting findings were presented by Kenneth Cho, MD, showcasing the benefits of mechanical thrombectomy (MT) for PE patients with severe PH. A study revealed reduced adverse events and improved quality of life in the long run for individuals treated with FlowTriever System, debunking previous safety concerns. The potential of MT in enhancing patient outcomes underscores the need for further research and updated treatment guidelines. Dive into the article to learn more about these promising results!
Mechanical Thrombectomy Improves Outcomes for Pulmonary Hypertension
snip.ly
-
Enrollment in the Pulmonary Hypertension Boot Camp, PHA Online University’s newest series, is open. This self-paced program is designed for clinicians seeking comprehensive, foundational knowledge of PH. This five-module program offers 3.0 hours of CE/CME credit. Enroll now. https://ow.ly/2Qt650RniM4
-
-
Enrollment in the Pulmonary Hypertension Boot Camp, PHA Online University’s newest series, is open. This self-paced program is designed for clinicians seeking comprehensive, foundational knowledge of PH. This five-module program offers 3.0 hours of CE/CME credit. Enroll now. https://ow.ly/gN9S50Rt7u1
-
-
A research investigation co-authored by Suneet Mittal, MD, FACC, FHRS, Chair of the Cardiovascular Service Line for Valley Health System, was recently published in JAMA. The study assessed the safety and effectiveness of percutaneous left atrial appendage ligation in addition to pulmonary vein isolation for non-paroxysmal atrial fibrillation. Results showed no significant difference in arrhythmia freedom at 12 months compared to ablation alone (64.3% vs. 59.9%). However, the combined treatment was safe, with a low 30-day adverse event rate of 3.4%. To read the full study, please visit https://lnkd.in/ewFHjEQF. #JAMA #JAMANetwork #MedicalResearch #ClinicalResearch #CardiacResearch #MedicalJournal
-
Chairman of Stocks🏦
1moInteresting